葡萄糖蛋白矩阵表现出改善的吸收:一个随机交叉试验
Ralf Jäger1, Martin Purpura1, Jaci Davis2
1Increnovo LLC, Whitefish Bay, WI 53217, USA.
Nutrients
|April 13, 2024
概括
与氧化相比,糖蛋白矩阵结合的 (GPM) 的吸收率明显更高. 这种增强的生物可用性表明GPM是一种优越的补充剂形式,可以改善营养吸收.
科学领域:
- 营养生物化学 营养生物化学
- 矿物代谢的矿物代谢.
- 食品科学 食品科学 食品科学
背景情况:
- 微生物生物转化矿物质通过糖化形成营养结合的食物矩阵.
- 这一过程提高了营养物质的生物可用性,特别是对于等矿物质.
- 糖蛋白矩阵结合 (GPM) 是一种新型的矿物补充剂.
研究的目的:
- 为了比较糖蛋白矩阵结合的 (GPM) 与无机氧化的吸收.
- 在人类参与者中评估GPM和氧化之间的药理学差异.
主要方法:
- 16名参与者从GPM或氧化中摄入了11毫克.
- 血液样本在摄入后多个时间点收集到480分钟.
- 分析了血液中的度,以确定吸收率.
主要成果:
- 摄入后120分钟,180分钟和240分钟,与氧化相比,GPM的度显著更高.
- GPM显著增加了曲线下的综合面积 (iAUC) 40%.
- GPM的Cmax值高出10%,尽管Tmax没有达到统计学意义.
结论:
- 与糖蛋白质矩阵结合的显示了与氧化相比显著增加的吸收.
- GPM代表了更具生物可用性的补充剂形式.
- 进一步的研究可能会探索GPM对状况的长期益处.
相关概念视频
Drug Absorption: Factors Affecting GI Absorption
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...
In...
Factors Influencing Drug Absorption: Anatomical Parameters
Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
Bioavailability Study Design: Absolute Versus Relative Bioavailability
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...


